American Healthcare REIT (NYSE:AHR) Issues Quarterly Earnings Results

American Healthcare REIT (NYSE:AHR) issued its earnings results on Thursday. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.40), FiscalAI reports. American Healthcare REIT had a net margin of 1.21% and a return on equity of 1.09%. The firm had revenue of $604.08 million during the quarter, compared to the consensus estimate of $617.49 million. During the same period in the previous year, the company posted $0.40 earnings per share. The firm’s revenue for the quarter was up 11.3% compared to the same quarter last year. American Healthcare REIT updated its FY 2026 guidance to 1.990-2.050 EPS.

American Healthcare REIT Price Performance

AHR stock opened at $53.25 on Friday. The stock has a market cap of $9.42 billion, a price-to-earnings ratio of 380.36, a P/E/G ratio of 2.01 and a beta of 1.03. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.44 and a quick ratio of 0.44. The company has a 50 day simple moving average of $48.74 and a 200 day simple moving average of $46.03. American Healthcare REIT has a 1 year low of $26.48 and a 1 year high of $53.54.

American Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 16th. Investors of record on Wednesday, December 31st were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Wednesday, December 31st. This represents a $1.00 annualized dividend and a dividend yield of 1.9%. American Healthcare REIT’s payout ratio is 714.29%.

Insider Buying and Selling at American Healthcare REIT

In other American Healthcare REIT news, Director Jeffrey T. Hanson sold 19,208 shares of the business’s stock in a transaction on Tuesday, December 23rd. The shares were sold at an average price of $48.40, for a total transaction of $929,667.20. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.92% of the company’s stock.

Institutional Investors Weigh In On American Healthcare REIT

A number of hedge funds and other institutional investors have recently bought and sold shares of AHR. Invesco Ltd. increased its holdings in American Healthcare REIT by 3.3% in the 4th quarter. Invesco Ltd. now owns 5,531,582 shares of the company’s stock worth $260,316,000 after purchasing an additional 177,033 shares in the last quarter. Corient Private Wealth LLC grew its holdings in shares of American Healthcare REIT by 28.1% during the fourth quarter. Corient Private Wealth LLC now owns 7,778 shares of the company’s stock worth $366,000 after purchasing an additional 1,708 shares during the last quarter. Mercer Global Advisors Inc. ADV increased its stake in shares of American Healthcare REIT by 177.2% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 21,529 shares of the company’s stock valued at $1,013,000 after buying an additional 13,762 shares during the period. EP Wealth Advisors LLC acquired a new position in shares of American Healthcare REIT in the fourth quarter valued at approximately $257,000. Finally, Garton & Associates Financial Advisors LLC bought a new position in American Healthcare REIT in the 4th quarter valued at approximately $26,000. Institutional investors own 16.68% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of American Healthcare REIT in a research report on Wednesday, January 21st. BMO Capital Markets started coverage on American Healthcare REIT in a report on Thursday, January 29th. They issued an “outperform” rating and a $55.00 price objective for the company. KeyCorp upped their target price on American Healthcare REIT from $43.00 to $55.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Scotiabank raised their price target on American Healthcare REIT from $47.00 to $55.00 and gave the stock a “sector outperform” rating in a research report on Thursday, November 13th. Finally, Royal Bank Of Canada boosted their price target on American Healthcare REIT from $45.00 to $54.00 and gave the company an “outperform” rating in a research note on Wednesday, November 12th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, American Healthcare REIT currently has an average rating of “Moderate Buy” and a consensus target price of $52.00.

About American Healthcare REIT

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.